Researchers from the Scadden Lab at MGH and Melton Lab at HSCRB present their recent work
Date and Time
Nov 22, 2019 12:00pm—1:00pm
Sherman Fairchild Room 268
The seminar will be live-streamed to conference room Karp 5 at Boston Children’s Hospital, located at 300 Longwood Avenue, Boston, MA 02115.
Cathy Rhee’s talk is titled “Clonal heterogeneity within the myeloid lineage”.
José Rivera-Feliciano’s talk is titled “A novel insulin-independent glucose lowering activity”.
Cathy Rhee, Ph.D.
Cathy Rhee, Ph.D., is a postdoctoral fellow in the Scadden Lab at Massachusetts General Hospital. Cathy’s graduate studies unveiled that Arid3a functions as a pivotal regulator of trophectoderm and placenta development by regulating the commitment to the first cell fate, as well as by executing trophectoderm lineage differentiation. She advanced the understanding of the mechanisms underlying transcription factor-mediated reprogramming of embryonic stem to trophoblast stem-like cells, in particular Arid3a-mediated transcriptional and epigenetic regulation.
Cathy’s current research focus in hematopoiesis. In the Scadden Lab, she examines epigenetic regulation of hematopoietic stem cell heterogeneity in multiple contexts.
José Rivera-Feliciano, Ph.D.
José Rivera-Feliciano, Ph.D., is a research associate in the Melton Lab here at HSCRB. His research focuses on applying the concepts in the fields of genetics, molecular biology, and regenerative biology, to design novel therapies for treating diabetes mellitus using stem cells.